Long-term outcome of acute myocarditis is independent of cardiac enzyme release

International Journal of Cardiology

Volumn 89, Issue 2-3, 2003, Pages 217-222

  Ammann, Peter ^a   Naegeli, Barbara ^a   Schuiki, Ernst ^a   Straumann, Edwin ^a   Frielingsdorf, Jürgen ^a   Rickli, Hans ^a   Bertel, Osmund ^a  

^a TRIEMLI HOSPITAL   (Switzerland)

Author keywords

Cardiac enzyme release; Cardiac troponin I; Left ventricular ejection fraction; Myocarditis

Indexed keywords

CREATINE KINASE; MYOGLOBIN; TROPONIN I;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HOSPITALIZATION; HUMAN; INFECTION; LONG TERM CARE; MALE; MYOCARDITIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0037722768     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00478-3     Document Type: Article

References (24)

1. Lauer B., Niederau C., Kuhl U., et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 30:1997;1354-1359.
2. Smith S.C., Ladenson J.H., Mason J.W., et al. Elevation of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation. 95:1996;163-168.
3. Angelini A., Calzolari V., Calabrese F., et al. Myocarditis mimicking acute myocardial infarction: role of endomyocardial biopsy in the differential diagnosis. Heart. 84:2000;245-250.
4. Yamashita T., Abe S., Arima S., et al. Myocardial infarction size can be estimated from serial plasma myoglobin measurement within 4 h of reperfusion. Circulation. 87:1993;1840-1849.
5. Feldman A.M., McNamara D. Medical progress: myocarditis. N Engl J Med. 343:2000;1388-1398.
6. Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. N Eng J Med. 333:1995;269-275.
7. Wynne J., Braunwald E. The cardiomyopathies and myocarditis. Braunwald E. Heart disease: a textbook of cardiovascular medicine. 5th ed:1997;1435-1445 W.B. Saunders, Philadelphia.
8. Aretz H.T. Myocarditis: the Dallas criteria. Hum Pathol. 18:1987;619-624.
9. Shanes J.G., Ghali J., Billingham M.E., et al. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation. 75:1987;401-405.
10. Lie J.T. Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease. Ann Intern Med. 109:1988;525-528.
11. Grogan M., Redfield M.M., Bailey K.R., et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 26:1995;80-84.
12. Sarda L., Colin P., Boccara F., et al. Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol. 37:2001;786-792.
13. Pinamonti B., Alberti E., Cigalotto A., et al. Echocardiographic findings in myocarditis. Am J Cardiol. 62:1988;285-291.
14. Karjalainen J., Heikkila J. Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J. 20:1999;1120-1125.
15. Kajalainen J., Heikkila J. 'Acute pericarditis': myocardial enzyme release as evidence for myocarditis. Am Heart J. 111:1986;546-552.
16. Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 72:1994;561-566.
17. Kumar A., Thota V., Dee L., Olson J., Uretz E., Parillo J.E. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 183:1996;949-958.
18. Parillo J.E. Pathogenetic mechanisms of septic shock. N Eng J Med. 328:1993;1471-1477.
19. Kumar A., Thota V., Dee L., Olson J., Uretz E., Parillo J.E. Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 183:1996;949-958.
20. Brett J., Gerlach H., Nawroth P., Steinberg S., Godman G., Stern D. Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med. 169:1989;1977-1991.
21. Piper H.M., Schwartz P., Spahr R., Hütter J.F., Spieckermann P.G. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol. 16:1984;385-388.
22. Fuse K., Kodama M., Okura Y., et al. Predictors of disease course in patients with acute myocarditis. Circulation. 102:2000;2829-2835.
23. Kanda T., Tanaka T., Sekiguchi K., et al. Effect of interleukin-18 on viral myocarditis: enhancement of interferon-gamma and natural killer cell activity. J Mol Cell Cardiol. 32:2000;2163-2171.
24. Kubota T., Bounoutas G.S., Miyagishima M., et al. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation. 101:2000;2518-2525.